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Severe sepsis is the leading cause of death in in-
tensive care units and accounts for 9% of deaths 
in the United States annually (1). Innate immune 
responses are critical for protection against lethal 
infection and tissue injury, but the uncontrolled 
production of proinfl   ammatory cytokines, in-
cluding TNF, IL-1, and high mobility group 
box 1 (HMGB1), causes the development of se-
vere sepsis (2–3). Counterregulatory antiinfl  am-
matory mediators, such as glucocorticoids and 
IL-10, normally suppress proinfl  ammatory cyto-
kine production to prevent excessive infl  am-
matory responses (4, 5). We recently discovered 
that the central nervous system also regulates 
proinfl  ammatory cytokine production through 
the eff  erent vagus nerve (5–9). Termed the 
“cholinergic antiinfl  ammatory pathway” because 
acetylcholine is the principal vagus neurotrans-
mitter, activation of this mechanism via vagus 
nerve stimulation can control the production 
of proinfl  ammatory cytokines in experimental 
models of systemic infl  ammation, including 
lethal endotoxemia, hemorrhagic shock, and 
ischemia-reperfusion injury (6–10).
Acetylcholine inhibits the production of 
proinfl  ammatory cytokines from endotoxin-
stimulated macrophages through a mechanism 
dependent on the α7 nicotinic acetylcholine 
receptor subunit (α7nAChR) (8, 11, 12). 
  Electrical vagus nerve stimulation fails to reduce 
serum TNF levels in α7nAChR-defi  cient mice, 
and macrophages derived from these knockout 
mice are insensitive to the cytokine-inhibiting 
eff  ects of cholinergic agonists, indicating that 
the α7nAChR is required for the antiinfl  am-
matory eff  ects of the vagus nerve (8). α7  agonists 
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The innate immune system protects against infection and tissue injury through the special-
ized organs of the reticuloendothelial system, including the lungs, liver, and spleen. The 
central nervous system regulates innate immune responses via the vagus nerve, a mecha-
nism termed the cholinergic antiinfl  ammatory pathway. Vagus nerve stimulation inhibits 
proinfl  ammatory cytokine production by signaling through the 𝗂7 nicotinic acetylcholine 
receptor subunit. Previously, the functional relationship between the cholinergic antiin-
fl  ammatory pathway and the reticuloendothelial system was unknown. Here we show that 
vagus nerve stimulation fails to inhibit tumor necrosis factor (TNF) production in splenec-
tomized animals during lethal endotoxemia. Selective lesioning of the common celiac nerve 
abolishes TNF suppression by vagus nerve stimulation, suggesting that the cholinergic 
pathway is functionally hard wired to the spleen via this branch of the vagus nerve. 
  Administration of nicotine, an 𝗂7 agonist that mimics vagus nerve stimulation, increases 
proinfl  ammatory cytokine production and lethality from polymicrobial sepsis in splenecto-
mized mice, indicating that the spleen is critical to the protective response of the choliner-
gic pathway. These results reveal a specifi  c, physiological connection between the nervous 
and innate immune systems that may be exploited through either electrical vagus nerve 
stimulation or administration of 𝗂7 agonists to inhibit proinfl  ammatory cytokine produc-
tion during infection and tissue injury.
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can inhibit activation of the transcriptional factor NF-κB, 
prevent secretion of HMGB1 and TNF, and improve survival 
during experimental polymicrobial sepsis (11, 12).  Collectively, 
these and other studies indicate that the cholinergic antiin-
fl  ammatory pathway has a critical role in modulating the im-
mune response to infection and injury (13, 14).
The reticuloendothelial system consists of macrophages 
and monocytes that target foreign pathogens in the lungs, liver, 
spleen, and other organs (15). These immune cells were origi-
nally grouped together because they engulfed vital dyes from 
the blood. It has since become clear that these cells are essential 
to the immediate, early response to circulating microbes and 
LPS, the bacterial endotoxin that stimulates tissue macrophages 
to secrete lethal quantities of proinfl  ammatory cytokines (16). 
Bacteria and endotoxin localize to macrophages primarily in 
the spleen and liver, which in turn become activated to produce 
proinfl  ammatory cytokines (17). Because the cholinergic anti-
infl  ammatory pathway inhibits early proinfl  ammatory cytokine 
production during endotoxemia, we reasoned that the principal 
physiological components of this pathway must reside there.
Accordingly, here we examined the eff  ects of vagus nerve 
stimulation and administration of α7nAChR agonists on pro-
infl  ammatory cytokine production in organs of the reticulo-
endothelial system during lethal endotoxemia and polymicrobial 
sepsis. The results indicate that splenectomy and selective ab-
dominal vagotomy inactivate the antiinfl  ammatory eff  ects of 
either vagus nerve stimulation or administration of α7nAChR 
agonists, and reveal that the spleen is a specifi  c and essential 
target of the cholinergic antiinfl  ammatory pathway.
RESULTS AND DISCUSSION
Spleen response to antiinfl  ammatory effects 
of vagus nerve stimulation
To explore the relationship between the reticuloendothelial 
system and the cholinergic antiinfl  ammatory pathway, we fi  rst 
measured individual organ TNF concentrations during lethal 
endotoxemia (Fig. 1 A). Endotoxin administration signifi  -
cantly increases TNF production in the spleen by a factor of 
30 as compared with six- and twofold increases in the lung 
and liver, respectively. Vagus nerve stimulation signifi  cantly 
reduces TNF levels in the spleen (94%) and liver (40%), but 
not in the lung (20%) (Fig. 1 A). Endotoxin signifi  cantly in-
creases TNF mRNA levels in the spleen and liver by 70- and 
23-fold, respectively. Vagus nerve stimulation signifi  cantly 
decreases TNF mRNA levels in the spleen, but it does not re-
duce TNF mRNA levels in the liver (Fig. 1 B). The reduction 
in splenic TNF mRNA levels mediated by vagus nerve stimu-
lation was confi  rmed using the RNase protection assay (not 
depicted). Collectively, these fi  ndings reveal that the spleen is 
an important source of TNF production that is regulated by 
the antiinfl  ammatory eff  ects of vagus nerve stimulation.
Vagus nerve stimulation fails to inhibit systemic TNF 
production in splenectomized animals
To determine the role of the spleen in the cholinergic anti-
infl  ammatory pathway, we subjected rats to splenectomy or 
sham surgery before lethal endotoxemia (Fig. 2 A). Splenec-
tomy signifi  cantly reduces serum TNF levels by 80% as com-
pared with sham controls, which match the 77% reduction in 
serum TNF levels after vagus nerve stimulation (Fig. 2 A). In 
contrast to the antiinfl  ammatory eff  ects of vagus nerve stimu-
lation in intact animals, we observed that vagus nerve stimu-
lation fails to inhibit serum TNF levels in splenectomized 
animals (Fig. 2 A). To explore the functional anatomy of this 
vagal antiinfl  ammatory pathway to the spleen, we performed 
selective abdominal vagotomies before vagus nerve stimula-
tion (Fig. 2, B and C). Inferior to the rat diaphragm, the ven-
tral vagus nerve trunk divides into gastric, hepatic, and celiac 
branches, and the dorsal vagus trunk divides into gastric and 
celiac branches (18, 19). Cervical vagus nerve stimulation at-
tenuates splenic and serum TNF levels in animals subjected to 
ventral subdiaphragmatic vagotomy. Common celiac branch 
vagotomy, however, abrogates the TNF-suppressing eff  ects 
of cervical vagus nerve stimulation in both the spleen and 
serum, indicating that intact vagal innervation via the com-
mon celiac branches are required for vagus nerve regulation 
of splenic and systemic TNF.
Vagus nerve regulation of TNF production in the spleen 
requires the 𝗂7nAChR
Regulation of serum TNF levels by vagus nerve stimulation 
is dependent on the α7nAChR (8, 11, 12). To determine the 
Figure 1.  Effect of vagus nerve stimulation on organ-specifi  c TNF 
production in lethal endotoxemia. (A) Lewis rats received electrical va-
gus nerve stimulation or sham stimulation 10 min before and 10 min after 
an LD50 dose of endotoxin (15 mg/kg, i.v.). Organs were collected after 90 
min, and TNF was normalized to the amount of protein per organ (n = 4–8 
per group). *, P < 0.01 versus control; **, P < 0.05 versus LPS; ***, P < 0.01 
versus LPS. (B) Effect of vagus nerve stimulation on hepatic and splenic 
TNF mRNA levels in lethal endotoxemia. Lewis rats received electrical vagus 
nerve stimulation or sham stimulation 10 min before and 10 min after 
endotoxin injection (15 mg/kg, i.v.). Organs were collected after 60 min, 
and TNF mRNA expression was determined by quantitative RT-PCR (n = 4–8 
per group). *, P < 0.01 versus control; **, P < 0.05 versus LPS.JEM VOL. 203, July 10, 2006  1625
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importance of the local α7nAChR antiinfl  ammatory response 
in the spleen, we measured TNF levels in the spleen after 
  vagus nerve stimulation of α7nAChR knockout mice (Fig. 
3 A). Western blot and immunohistochemical analyses con-
fi  rmed the presence of splenic α7nAChR expression in wild-
type mice, but not in α7nAChR knockout mice (Fig. 3 A, 
inset). Vagus nerve stimulation in α7nAChR knockout 
mice fails to inhibit TNF production in the spleen. Consis-
tent with our previous studies, vagus nerve stimulation in 
α7nAChR knockout mice also fails to inhibit serum TNF 
levels (Fig. 3 B).
The α7nAChR response in the spleen was studied using 
endotoxin-stimulated splenocytes isolated from wild-type 
and α7nAChR-defi  cient animals. Endotoxin signifi  cantly in-
creases TNF levels in both wild-type and α7 knockout sple-
nocytes. Acetylcholine signifi  cantly inhibits TNF release in 
endotoxin-stimulated splenocytes from wild-type mice, but 
not in splenocytes from α7nAChR-defi  cient animals (Fig. 3 C), 
indicating that like macrophages, splenocytes are unable to 
respond to cholinergic antiinfl  ammatory signaling in the ab-
sence of the α7nAChR. To determine the cytokine specifi  c-
ity of splenic cholinergic signaling, we analyzed the expression 
Figure 2.  Vagus nerve stimulation fails to inhibit systemic TNF 
production in splenectomized animals. (A) Lewis rats underwent sple-
nectomy or sham surgery, and 3 d later they were injected with endotoxin 
(15 mg/kg, i.v.) and treated with vagus nerve stimulation or sham stimula-
tion. Serum was collected after 90 min. Data are presented as mean ± 
SEM (n = 6 per group). *, P < 0.01 versus control; **, P < 0.05 versus LPS. 
(B and C) The common celiac vagus branches mediate the TNF-suppress-
ing effect of vagus nerve stimulation. Selective subdiaphragmatic ventral 
vagotomy (VVgx) or common celiac branch vagotomy (CVgx) was per-
formed before endotoxin administration (15 mg/kg, i.v.) and vagus nerve 
stimulation or sham stimulation. TNF concentrations in rat spleen and 
serum were determined after 90 min. Data are presented as mean ± SEM 
(n = 5 per group). *, P < 0.01 versus control; **, P < 0.05 versus LPS.
Figure 3.  Vagus nerve regulation of TNF production in the spleen 
requires the 𝗂7nAChR. (A and B) Wild-type (+/+) and α7nAChR-defi  -
cient mice (−/−) received vagus nerve stimulation before endotoxin ad-
ministration (7.5 mg/kg, i.p.). TNF concentrations were measured in the 
spleen and serum after 90 min. Data are presented as mean ± SEM (n = 10 
per group). **, P < 0.05. (C) Regulation of splenocyte TNF production by 
acetylcholine requires the α7nAChR. Primary splenocyte cultures from 
wild-type (+/+) and α7nAChR-defi  cient mice (−/−) were treated with 
endotoxin in the presence of acetylcholine. Data are presented as mean ± 
SEM. **, P < 0.05. (D) Acetylcholine does not affect splenocyte TGF-β 
production. Primary splenocyte cultures from wild-type (+/+) and 
α7nAChR-defi  cient mice (−/−) were treated with endotoxin in the 
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of TGF-β, an antiinfl   ammatory cytokine (20). Endotoxin 
stimulation increased TGF-β expression in splenocyte cul-
tures from wild-type and α7nAChR-defi  cient  animals. 
  Acetylcholine did not signifi  cantly alter TGF-β expression 
in splenocyte cultures obtained from either wild-type or 
α7nAChR-defi  cient animals (Fig. 3 D), suggesting that the 
pathway is specifi  c. These fi  ndings indicate that the α7nAChR 
response is a necessary molecular component of vagus nerve 
antiinfl  ammatory signaling in the spleen.
Nicotine worsens survival in splenectomized animals 
with lethal polymicrobial sepsis
Administration of nicotine protects mice against the lethality 
of polymicrobial sepsis by inhibiting proinfl  ammatory cyto-
kine production via an α7nAChR-dependent mechanism 
(11). To determine the role of the spleen in this pathway, 
splenectomized mice subjected to cecal perforation were 
treated with nicotine. We observed that nicotine not only 
fails to protect against sepsis lethality in splenectomized mice, 
but it actually worsens survival (Fig. 4 A). Previously, the 
survival benefi  ts of nicotine were found to correlate with re-
duced serum levels of HMGB1, a necessary and suffi   cient 
mediator of lethal systemic infl  ammation (11). Here we ob-
served that nicotine not only fails to inhibit, but it actually 
signifi   cantly increases serum HMGB1 levels in splenecto-
mized animals (Fig. 4 B). There were no diff  erences in circu-
lating TNF, IL-12, IFN-γ, or IL-10 levels between vehicle- or 
nicotine-treated animals (not depicted). These fi  ndings indi-
cate that the protective eff  ects of nicotine in lethal sepsis 
  require the spleen, and suggest that splenectomy eliminates 
nicotine’s ability to regulate circulating HMGB1 levels.
Cholinergic antiinfl  ammatory pathway innervation 
of the spleen
The innate immune system coordinates the early and rapid 
defense against invasive pathogens and toxins (21–22). The 
  aff  erent, sensory arm of the vagus nerve is critical to the central 
nervous system’s response to toxins in the peripheral immune 
environment (23–24). The cholinergic antiinfl  ammatory path-
way is the eff  erent arm of this vagus nerve–mediated, brain-to-
immune pathway that inhibits systemic proinfl  ammatory 
cytokine production by signaling through the α7nAChR 
(5–12). We studied the functional relationship between 
the innate immune system and the cholinergic antiinfl  am-
matory pathway and found a specifi  c, α7nAChR-dependent 
vagus nerve pathway to the spleen that inhibits proinfl  am-
matory cytokine production during lethal endotoxemia and 
polymicrobial sepsis. Interruption of this pathway via splenec-
tomy or selective abdominal vagotomy completely abolishes 
the protective, antiinfl  ammatory eff  ects of the cholinergic 
antiinfl  ammatory pathway.
Vagus nerve stimulation signifi  cantly reduces TNF pro-
tein levels in the spleen and liver, and specifi  cally reduces 
TNF mRNA levels in the spleen, but not liver. These fi  nd-
ings indicate that the vagus nerve is an early and local modu-
lator of proinfl  ammatory cytokine production in the spleen 
and suggest that this specifi  c regulation of TNF production 
occurs at the transcriptional level. Splenectomy reduces sys-
temic TNF production by 80% during lethal endotoxemia, 
suggesting that the spleen is a major contributor to systemic 
TNF production in this experimental model. Vagus nerve 
stimulation fails to inhibit proinfl  ammatory cytokine produc-
tion after splenectomy or selective interruption of the ab-
dominal vagus nerve at the common celiac branch. Thus, 
signals originating in the vagus nerve traverse the common 
celiac branch to control proinfl  ammatory cytokine produc-
tion in the spleen.
Vagus nerve stimulation fails to regulate splenic TNF pro-
duction in α7nAChR-defi  cient mice, and splenocytes from 
α7 knockout mice do not respond to in vitro stimulation with 
acetylcholine. Administration of the α7 nicotinic nicotine to 
splenectomized animals signifi  cantly increases mortality and 
serum HMGB1 levels, whereas we previously demonstrated 
that nicotine signifi  cantly improves survival and attenuates 
circulating HMGB1 levels in nonsplenectomized mice by 
acting through the α7nAChR (11, 12). These results indicate 
that the spleen is essential to the α7nAChR-dependent pro-
tective antiinfl  ammatory response. It is possible that the wors-
ened survival after nicotine treatment is related to nicotinic 
suppression of normal immune responses in the absence of the 
spleen. In agreement with this hypothesis, previous studies 
indicate that nicotine can signifi  cantly impair antimicrobial 
activity in macrophages lacking the α7nAChR via its action 
on other non-α7 acetylcholine receptor subtypes (25).
Figure 4.  Nicotine worsens survival in splenectomized animals 
with lethal polymicrobial sepsis. (A) BALB/c mice were subjected to 
splenectomy before cecal ligation and puncture (CLP). Nicotine (400 μg/kg, 
i.p.) or vehicle treatment began 24 h later and was administered twice a 
day for 3 d. Data are shown as percent of animals surviving (n > 20 per 
group). *, P < 0.05 versus control; **, P < 0.05 versus CLP. (B) Nicotine 
increases serum HMGB1 levels in splenectomized animals. BALB/c mice 
were subjected to splenectomy before cecal ligation and puncture, and 
nicotine (400 μg/kg, i.p.) or vehicle treatment began 24 h after surgery. 
Blood was collected 44 h after surgery, and serum HMGB1 concentration 
was determined by Western blot and densitometric analysis. Data are 
presented as mean ± SEM (n > 8 per group). **, P < 0.05.JEM VOL. 203, July 10, 2006  1627
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Collectively, these fi  ndings have important implications 
for the development of therapeutic, selective α7nAChR 
agonists. It may be necessary to develop methods that 
  specifi  cally target the critical, α7nAChR antiinfl  ammatory 
response peripherally in the spleen as well as to consider 
methods to stratify patients who may or may not benefi  t 
from activation of the cholinergic antiinfl  ammatory pathway. 
Vagus nerve modulation of the spleen may represent the 
functionally, hard-wired counterpart to humoral antiin-
fl  ammatory responses, such as the hypothalamic–pituitary–
adrenal axis (26). The neural connection between the   vagus
nerve and the spleen can allow for rapid and precise 
control of systemic cytokine production. It may also con-
trol the traffi   cking of infl  ammatory cells to distant sites (27). 
  Vagus nerve stimulation is clinically approved for the treat-
ment of medically refractory seizures, and more than 25,000 
individuals have undergone this safe and well-tolerated 
therapy worldwide (28, 29). Future studies are needed to 
explore the protective eff  ects of vagus nerve stimulation and 
α7nAChR agonists in the treatment of systemic infl  amma-
tion and sepsis.
MATERIALS AND METHODS
Animals. Adult male Lewis rats (280–300 g; Charles River Laboratories), 
male 8–12-wk-old BALB/c mice (25–30 g; Taconic), and male and female 
8–12-wk-old α7nAChR-defi  cient mice (C57BL/6 background) as well as 
wild-type littermates (The Jackson Laboratory) were housed at 25°C on a 
12-h light/dark cycle. Standard animal chow and water were freely available. 
All experiments were performed under protocols approved by the Institu-
tional Animal Care and Use Committee of The Feinstein Institute for Medi-
cal Research, North Shore-LIJ Health System.
Endotoxemia. Endotoxin (Escherichia coli LPS 0111:B4; Sigma-Aldrich) 
was dissolved in sterile pyrogen-free PBS and sonicated for 30 min immedi-
ately before use. Animals received an LD50–75 dose of LPS (7.5–15 mg/kg). 
Blood was collected after 90–120 min, allowed to clot for 2 h at room tem-
perature, and centrifuged for 15 min at 2,000 g. TNF concentrations were 
measured by ELISA (R&D Systems).
Vagus nerve stimulation. Animals were anesthetized i.m. with 100 mg/kg 
ketamine and 10 mg/kg xylazine, and subjected to sham surgery (sham) 
or left cervical vagotomy with electrical stimulation of the distal nerve trunk. 
In sham-operated animals, the vagal trunk was exposed but not divided. The 
nerve trunk was placed across a bipolar platinum electrode (Plastics One) 
connected to a stimulation module (STM100A) controlled by AcqKnowl-
edge software (Biopac Systems). Stimulation (1 V, 2 ms, 5 Hz) was applied 
for 10 min before and after endotoxin administration.
Subdiaphragmatic vagotomy. Animals were anesthetized with ketamine 
and xylazine. After an upper midline laparotomy, the stomach was retracted 
inferiorly to access the common celiac and ventral vagus nerve trunks, and 
vagotomy was performed by ligating and excising at least 1 cm of either the 
ventral vagus nerve or both common celiac branches. For sham controls, the 
vagal trunks were exposed but not ligated.
Cecal ligation and puncture. Cecal ligation and puncture were per-
formed on BALB/c mice as described previously (11). Animals received an-
tibiotic (0.5 mg/kg Primaxin, s.c.) and 0.9% normal saline (20 ml/kg body 
weight, s.c.) immediately after surgery. i.p. administration of 400 μg/kg 
nicotine or vehicle injection (1× PBS) began 24 h after surgery, and there-
after twice a day for 3 d. Animals were killed after 44 h for serum cytokine 
analysis. Serum HMGB1 levels were determined by Western blot as we de-
scribed previously (11). HMGB1 concentrations were calculated against 
standard curves of purifi  ed recombinant HMGB1, which was purifi  ed as 
described previously (11). Serum TNF, IL-12, IFN-γ, and IL-10 levels 
were measured using Cytometric Bead Array (Becton Dickinson) according 
to the manufacturer’s instructions.
Splenectomy. Mice were anesthetized with ketamine and xylazine. The 
spleen was identifi  ed after a midline laparotomy incision and removed after 
appropriate blood vessel ligation. Sham animals underwent laparotomy 
without splenectomy.
Splenocyte culture. Spleens were mechanically disrupted with a 100-μm 
pore cell strainer (BD Falcon), erythrocytes were lysed in solution   (Gentra 
  Systems) for 10 min, and intact cells were washed twice in PBS. Cells were 
  resuspended in medium (RPMI, FBS 10%, 2 mM l-glutamine, 100 U/ml 
penicillin/100μg/ml streptomycin) and plated at a fi  nal density of 5 × 105 
cells/well. Splenocytes were incubated for 10 h with 50 ng/ml LPS 
(E. coli 0111:B4; Sigma-Aldrich) plus or minus acetylcholine (0, 1, 10, and 
100 μM; Sigma-  Aldrich) combined with 1 mM pyridostigmine bromide 
(Sigma-Aldrich).   Supernatant cytokine levels were measured by ELISA 
(R&D Systems).
Quantitative RT-PCR. Frozen spleen and liver samples were homoge-
nized before total RNA isolation using an RNeasy kit and QIAshredder 
mini-spin columns (QIAGEN) and treated with DNase to remove genomic 
contamination (QIAGEN). The relative expression of TNF mRNA was de-
termined by quantitative real-time PCR using TaqMan technology using 
the Eurogentec’s RTqPCR mastermix and the ABI PRISM 7700 Sequence 
Detection System. Optimal concentrations of primers, probes, and the RNA 
were standardized. TNF primer (forward: G  C  T  G  C  C  C  C  G  A  C  T  A  T  G  T  G-
C  T  , reverse: G  A  C  T  T  T  C  T  C  C  T  G  G  T  A  T  G  A  A  A  T  G  G  C  ) was added at a fi  nal 
concentration of 900 nM. Mouse GAPDH was used as an internal control 
gene, and mouse GAPDH primers (forward: T  G  T  G  T  C  C  G  T  C  G  T  G  G  A  T  C-
T  G  A  , reverse: C  C  T  G  C  T  T  C  A  C  C  A  C  C  T  T  C  T  T  G  A  ) and the GAPDH Taq-
Man probe (C  C  G  C  C  T  G  G  A  G  -A  A  A  C  C  T  G  C  C  A  ) were added at fi  nal 
concentrations of 500 nM and 100 nM, respectively. The thermal cycler 
conditions were 35 cycles of 94°C for 20 s, 55°C for 20 s, and 72°C for 30 s. 
Data were analyzed using Sequence Detection System software version 
1.9.1. Relative expression of the TNF gene in the spleen and liver obtained 
from mice treated with endotoxin or endotoxin plus vagus nerve stimulation 
was calculated in comparison to vehicle-treated control samples using the 
delta delta Ct method (User Bulletin no. 2; Applied Biosystems). All samples 
were run in duplicate.
RNase protection assay. Total RNA was extracted using the RNeasy 
Mini kit (catalog no. 74104; QIAGEN) according to the manufacturer’s in-
structions (Tel-Test B Inc.). Purity and integrity of the preparation were 
verifi  ed by electrophoresis on 1.2% agarose/17% formaldehyde gels and by 
RT-PCR for TNF mRNA. Extraction effi   ciency was measured by absor-
bance to normalized concentrations of total RNA. TNF and actin mRNA 
in the spleen and liver were measured by RNase protection assay using the 
RPA III kit (catalog no. 1415; Ambion). The antisense RNA probe was la-
beled with 800 Ci/mmol α-32P-UTP (GE Healthcare) using T7 RNA poly-
merase. Molecular weight markers were prepared using RNA Century 
marker template set (catalog no. 7780; Ambion) transcribed using a Maxis-
cript kit (catalog no. 1308-1326; Ambion) with 800 Ci/mmol α-32P-dUTP 
(GE Healthcare). mRNA levels were measured with an InstantImager 
(Packard Instrument Co.).
Statistical analysis. All data in the fi  gures and text are expressed as mean 
± SEM. One-way ANOVA using the Bonferroni correction was used to 
compare mean values between multiple groups. The Student’s t test was used 
to compare mean values between two experimental groups. Diff  erences 
in survival were determined using the log-rank test. p-values <0.05 were 
considered signifi  cant.1628  SPLENECTOMY INACTIVATES CHOLINERGIC ANTIINFLAMMATORY PATHWAY | Huston et al.
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